MedTrace Logo

Acceptability/Feasibility of HIV Testing by ELISA or Rapid Test to Adult Patients in Paris, France

NCT02574208 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2016-11-22

No results posted yet for this study

Summary

CDC recommends universal HIV testing in all adults, at least once during life, to reduce the pool of infected patients unaware of their status. Routine universal HIV testing can use "classical" ELISA tests from serum, or rapid tests, ideally from finger-stick whole blood (FSB), which have shown close predictive values from classical tests. The investigators will compare the acceptability and feasibility of the two methods.

Conditions

Interventions

PROCEDURE

HIV testing by ELISA

HIV testing randomized between ELISA or rapid test

PROCEDURE

HIV testing by rapid test

HIV testing randomized between ELISA or rapid test

Sponsors & Collaborators

  • Hopital Lariboisière

    lead OTHER

Principal Investigators

  • Pierre O Sellier, M.D., Ph.D. · Hopital Lariboisiere

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2015-12-31
Completion
2016-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02574208 on ClinicalTrials.gov